Medical Device | September 19, 2023
Remedi introduces best handheld X-ray solution to India
This X-ray device is not only low-dose but also lightweight, making it the perfect tool for quick & accurate diagnoses
This X-ray device is not only low-dose but also lightweight, making it the perfect tool for quick & accurate diagnoses
Approval is for use in myelofibrosis patients with anaemia regardless of prior myelofibrosis therapy
The Government of India continues to prioritise initiatives aimed at enhancing the accessibility and equity of health services
Free Treatment, investigations and sex change surgery along with other facilities will be available at these OPDs for the Transgender community
Public private partnership (PPP) with integrated strategy essential to achieve ‘TB Mukt Bharat’ by 2025
Approval of this product under the PEPFAR program completes Strides’ qualification to all major markets and donor programs including Global Fund and South Africa
Currently, Praveen Akkinepally is the Head of Lung Cancer Commercialization, AstraZeneca Gaithersburg, MD, USA
Norelgestromin and Ethinyl Estradiol Transdermal System, 150 mcg/35 mcg per day had annual sales of US $330 million in the United States
This advanced technology is specifically tailored for individuals with high power prescriptions, aiming to free the 18-35 age group from the reliance on eyeglasses
The products will be manufactured at the company's facility in Bengaluru
Subscribe To Our Newsletter & Stay Updated
